Colorectal cancer is the third most common cancer in men and the second in women world wide. The majority of the cases of acute neoplastic large bowel obstruction are secondary to colorectal cancer. The other reasons are those from ovarian cancer, bladder cancer, metastatic pelvic cancer, lymphoma, sarcoma. Surgery is the corner stone of CRC cancer treatment and is generally under taken within 6-8 months of diagnosis. The vastmajority of colon cancers can be resected with curative intent. As a result hundreds of thousands of people with resected CRC are candidates for surveillance. As a whole patients with malignant colonic obstruction carry greater risk of poor outcome from the therapeutic procedures and they have shorter surveillance and survival rate, compared with those without complicated course of CRC. Therapeutic strategy in patients with neoplastic large bowel obstruction is mainly determined by location of the obstruction, clinical stage and performance status. Therapeutic strategy in those patients could one of the most challenging clinical scenaria, balansing between advantages/benefits and disadvantages of surgical interven tions and procedures, there prognosis and outcome, tumor biology and last but not least, the quality of life of the patients.
SSM, 2012;44(1):21-27
Email this article (Login required) 
